Abstract
ERK1 and ERK2 (ERK1/2) are the primary effector kinases of the RAS-RAF-MEK-ERK signaling pathway. A variety of substrates and regulatory partners associate with ERK1/2 through distinct D-peptide- and DEF-docking sites on their kinase domains. While understanding of D-peptides that bind to ERK1/2 has become increasingly clear over the last decade, only more recently have structures of proteins interacting with other binding sites on ERK1/2 become available. PEA-15 is a 130-residue ERK1/2 regulator that engages both the D-peptide- and DEF-docking sites of ERK kinases, and directly sequesters the ERK2 activation loop in various different phosphorylation states. Here we describe the methods used to derive crystallization-grade complexes of ERK2-PEA-15, which may also be adapted for other regulators that associate with the activation loop of ERK1/2.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298:1911–1912
Plotnikov A, Zehorai E, Procaccia S et al (2011) The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 1813:1619–1633
Kan Z, Jaiswal BS, Stinson J et al (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466:869–873
Gray-Schopfer V, Wellbrock C, Marais R (2007) Melanoma biology and new targeted therapy. Nature 445:851–857
Roskoski R (2012) ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 66:105–143
Kim EK, Choi E-J (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 1802:396–405
Tidyman WE, Rauen KA (2009) The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 19:230–236
Chico LK, Van Eldik LJ, Watterson DM (2009) Targeting protein kinases in central nervous system disorders. Nat Rev Drug Discov 8:892–909
Good MC, Zalatan JG, Lim WA (2011) Scaffold proteins: hubs for controlling the flow of cellular information. Science 332:680–686
Zhang Y-Y, Wu J-W, Wang Z-X (2011) Mitogen-activated protein kinase (MAPK) phosphatase 3-mediated cross-talk between MAPKs ERK2 and p38alpha. J Biol Chem 286:16150–16162
Caunt CJ, Keyse SM (2013) Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling. FEBS J 280:489–504
Yao Y, Li W, Wu J et al (2003) Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation. Proc Natl Acad Sci U S A 100:12759–12764
Kornev AP, Taylor SS (2010) Defining the conserved internal architecture of a protein kinase. Biochim Biophys Acta 1804:440–444
Taylor SS, Kornev AP (2011) Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci 36:65–77
Haystead TA, Dent P, Wu J et al (1992) Ordered phosphorylation of p42mapk by MAP kinase kinase. FEBS Lett 306:17–22
Burack WR, Sturgill TW (1997) The activating dual phosphorylation of MAPK by MEK is nonprocessive. Biochemistry 36:5929–5933
Ferrell JE, Bhatt RR (1997) Mechanistic studies of the dual phosphorylation of mitogen-activated protein kinase. J Biol Chem 272:19008–19016
Prowse CN, Lew J (2001) Mechanism of activation of ERK2 by dual phosphorylation. J Biol Chem 276:99–103
Canagarajah BJ, Khokhlatchev A, Cobb MH et al (1997) Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90:859–869
Casar B, Pinto A, Crespo P (2009) ERK dimers and scaffold proteins: unexpected partners for a forgotten (cytoplasmic) task. Cell Cycle 8:1007–1013
Casar B, Pinto A, Crespo P (2008) Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes. Mol Cell 31:708–721
Khokhlatchev AV, Canagarajah B, Wilsbacher J et al (1998) Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93:605–615
Herrero A, Pinto A, Colón-Bolea P et al (2015) Small molecule inhibition of ERK dimerization prevents tumorigenesis by RAS-ERK pathway oncogenes. Cancer Cell 28:170–182
Zhou T, Sun L, Humphreys J et al (2006) Docking interactions induce exposure of activation loop in the MAP kinase ERK2. Structure 14:1011–1019
Ma W, Shang Y, Wei Z et al (2010) Phosphorylation of DCC by ERK2 is facilitated by direct docking of the receptor P1 domain to the kinase. Structure 18:1502–1511
Liu S, Sun J-P, Zhou B et al (2006) Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. Proc Natl Acad Sci U S A 103:5326–5331
Garai A, Zeke A, Gógl G et al (2012) Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove. Sci Signal 5:74
Lee T, Hoofnagle AN, Kabuyama Y et al (2004) Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. Mol Cell 14:43–55
Peti W, Page R (2013) Molecular basis of MAP kinase regulation. Protein Sci 22:1698–1710
Francis DM, Różycki B, Tortajada A et al (2011) Resting and active states of the ERK2:HePTP complex. J Am Chem Soc 133:17138–17141
Mace PD, Wallez Y, Egger MF et al (2013) Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK. Nat Commun 4:1681
Kummer L, Parizek P, Rube P et al (2012) Structural and functional analysis of phosphorylation-specific binders of the kinase ERK from designed ankyrin repeat protein libraries. Proc Natl Acad Sci U S A 109:E2248–E2257
Alexa A, Gógl G, Glatz G et al (2015) Structural assembly of the signaling competent ERK2-RSK1 heterodimeric protein kinase complex. Proc Natl Acad Sci U S A 112:2711–2716
Wu J, Rossomando AJ, Her JH (1991) Autophosphorylation in vitro of recombinant 42-kilodalton mitogen-activated protein kinase on tyrosine. Proc Natl Acad Sci U S A 88:9508–9512
Seeliger MA, Young M, Henderson MN et al (2005) High yield bacterial expression of active c-Abl and c-Src tyrosine kinases. Protein Sci 14:3135–3139
Khokhlatchev A, Xu S, English J et al (1997) Reconstitution of mitogen-activated protein kinase phosphorylation cascades in bacteria. Efficient synthesis of active protein kinases. J Biol Chem 272:11057–11062
Luna-Vargas MPA, Christodoulou E, Alfieri A et al (2011) Enabling high-throughput ligation-independent cloning and protein expression for the family of ubiquitin specific proteases. J Struct Biol 175:113–119
Butt TR, Edavettal SC, Hall JP et al (2005) SUMO fusion technology for difficult-to-express proteins. Protein Expr Purif 43:1–9
Acknowledgements
This work was supported by NIH grants R01AA017238, 1R01CA160457 (to S.J.R.), and a DOD-BCRP Fellowship BC100466 to P.D.M. P.D.M. and J.F.W. are currently supported by a Rutherford Discovery Fellowship from the New Zealand government administered by the Royal Society of New Zealand (to P.D.M.). The original pET-LIC vector used in this work was kindly gifted by the Netherlands Cancer Institute (NKI) Protein Facility with funding from grant no. 175.010.2007.012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Weijman, J.F., Riedl, S.J., Mace, P.D. (2017). Structural Studies of ERK2 Protein Complexes. In: Jimenez, G. (eds) ERK Signaling. Methods in Molecular Biology, vol 1487. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6424-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6424-6_4
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6422-2
Online ISBN: 978-1-4939-6424-6
eBook Packages: Springer Protocols